• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN MFG SOLUTIONS S.A. PERMCATH; CATHETER, SUBCLAVIAN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN MFG SOLUTIONS S.A. PERMCATH; CATHETER, SUBCLAVIAN Back to Search Results
Model Number 8834369001
Medical Device Problem Codes Break (1069); Product Quality Problem (1506)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 02/06/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
According to the reporter, during use, the catheter was corrupted in the patients pleura region.There was leak in the intra pleural.Chlorhexidine was used as a cleaning agent.A medical intervention was done to relocate the catheter and implant another.The patient extended their hospitalization.
 
Event or Problem Description
According to the reporter, during use, the catheter was corrupted in the patients pleura region.There was a leak in the intra pleura.It was stated that the insertion site was via intra-atrial thoracotomy.Chlorhexidine was used as a cleaning agent.A medical intervention was done to relocate the catheter and implant another and patient was injected with electrolyte solution.The hemodialysis treatment was delayed.The patient hospitalization was extended.
 
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
Evaluation summary: post market vigilance (pmv) led a photographic evaluation of one device.Visual inspection and functional testing confirmed there were no abnormalities that would have caused or contributed to the reported condition.Records from each manufacturing lot are thoroughly reviewed to ensure that products are released meeting all quality release specifications at the time of manufacture.The investigation concluded there were no abnormalities that would have caused or contributed to the reported condition.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
According to the reporter, during use, the catheter was corrupted/broke in the patients pleura region.There was a leak in the intra pleura.It was stated that the insertion site was via intra-atrial thoracotomy.Chlorhexidine was used as a cleaning agent.A medical intervention was done to relocate the catheter and implant another and patient was injected with electrolyte solution.The catheter was replaced.The hemodialysis treatment was delayed.The patient hospitalization was extended.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERMCATH
Common Device Name
CATHETER, SUBCLAVIAN
Manufacturer (Section D)
COVIDIEN MFG SOLUTIONS S.A.
edificio b20, calle #2
alajuela 20101
MDR Report Key8386789
Report Number3009211636-2019-00054
Device Sequence Number1795015
Product Code LFJ
UDI-Device Identifier20884521009902
UDI-Public20884521009902
Combination Product (Y/N)N
Initial Reporter CountryBR
PMA/510(K) Number
K871942
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date (Section B) 05/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number8834369001
Device Catalogue Number8834369001
Device Lot Number1724900137
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 02/07/2019
Supplement Date Received by Manufacturer02/18/2019
05/06/2019
Initial Report FDA Received Date03/04/2019
Supplement Report FDA Received Date03/19/2019
05/23/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age12 YR
Patient Weight28
-
-